Add BrightSurf on Google Email

Noninvasive prenatal testing by analyzing mother's blood

Researchers have identified a pattern of fetal mRNAs detectable in pregnant women's blood, which could serve as a baseline for diagnosing genetic diseases. This detection method has the potential to replace invasive prenatal procedures, offering a new approach to monitoring fetal health.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 20, 2007

Smart insulin nanostructures pass feasibility test, UT study reports

Researchers at UT Health Science Center have developed a smart particle insulin release system that detects blood sugar spikes and releases insulin to counteract them. The system, which consists of a blood sugar sensing protein and liposomes loaded with insulin, stabilized blood sugar levels in animal models for up to six hours.

SourceUniversity of Texas Health Science Center at Houston·JournalInternational Journal of Nanomedicine·DateSep 20, 2007

New study may explain Vioxx side effects

A new study published in the Journal of Experimental Medicine suggests that COX-2 inhibitors like Vioxx trigger life-threatening side effects by stimulating blood clotting. The researchers propose a solution by administering TF-reducing drugs alongside Cox-2 inhibitors to treat people safely

SourceJournal of Experimental Medicine·JournalJournal of Experimental Medicine·DateAug 27, 2007

Restricting blood flow in the arm to protect the heart?

Researchers found that restricting blood flow in the arm before coronary artery bypass graft surgery reduced troponin T levels by 43%. This technique, known as remote ischaemic preconditioning, may help protect the heart from injury during surgery. The study's implications for clinical practice are considered immense.

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 16, 2007

Chemotherapy with bevacizumab increases risk of blood clots in arteries

A study published in the Journal of the National Cancer Institute found that chemotherapy with bevacizumab increases the risk of blood clots in arteries, with a higher incidence among patients over 65 years old. The risk of arterial thromboembolic events was significantly higher in patients treated with the combination therapy compared...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateAug 7, 2007

Older is better -- Top-10 comparison of diabetes drugs give metformin top grade

A study by Johns Hopkins Medicine found that metformin, a widely used diabetes medication, offers distinct advantages over nine other medications in controlling blood sugar levels, weight gain, and bad cholesterol levels. The medication was also found to be less expensive than newer options, with annual treatment costs averaging $100.

SourceJohns Hopkins Medicine·JournalAnnals of Internal Medicine·DateJul 24, 2007

Venous thromboembolism risk among hospitalized patients

A study estimates nearly one-third of hospitalized US patients are vulnerable to VTE, which can lead to dire complications. Researchers stress the need for reinforcing national guidelines and monitoring compliance with hospital protocols for VTE prevention, as well as educating outpatients on preventive measures.

SourceWiley·JournalAmerican Journal of Hematology·DateJul 13, 2007

Blood clotting protein may inhibit spinal cord regeneration

Researchers at the University of California, San Diego discovered that fibrinogen inhibits neural cell growth in spinal cord injuries, leading to paralysis. The study found that fibrinogen's binding to beta 3 integrin receptor and epidermal growth factor receptor prevents axonal growth, which is necessary for regeneration.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateJul 3, 2007

Metabolic syndrome points to heart health

A study found that metabolic syndrome is associated with compromised heart structure and function, including symptomatic heart failure. The association was independent of coronary heart disease risk as predicted by the Framingham risk score for diastolic dysfunction, but not systolic dysfunction.

SourceBMC (BioMed Central)·JournalBMC Cardiovascular Disorders·DateJun 6, 2007

Decapitation and rebirth

A newly excavated headless skeleton from Nasca, Peru provides important new data on ancient decapitation practices. The analysis suggests that decapitation was part of powerful rituals aimed at ensuring fertility and the continuation of life and rebirth of the community.

SourceUniversity of Chicago Press Journals·JournalCurrent Anthropology·DateMay 29, 2007

Pistachios lower cholesterol, provide antioxidants

Researchers found that pistachio amounts of 1.5 ounces reduced LDL cholesterol levels by 11.6% and total cholesterol by 8.4%, while the higher dose showed significant reductions in lipoprotein ratios. Pistachios also increased antioxidants in the blood, which may help reduce inflammation.

Rotavirus can spread beyond the intestine

A new study found that rotavirus, a common cause of diarrhea in children, can also be present systemically, with infectious virus detected in the blood of infected children. The presence of virus in the blood is directly related to the presence of antigen but independent of diarrhea.

SourcePLOS·JournalPLOS Medicine·DateApr 16, 2007

Learning from both ends of the stethoscope

A systematic review of studies published over four decades confirms that good doctor-patient communication significantly impacts patient outcomes, including resolution of chronic headaches and improved blood pressure readings. The review highlights the importance of clarifying instructions and checking for understanding to ensure effec...

SourceIndiana University·JournalMedical Care·DateApr 9, 2007

Tumors stopped from spreading to new sites

Researchers found that TGF-beta inhibitors can block lung metastases in breast cancer mice treated with radiation or doxorubicin. Monitoring TGF-beta levels could identify at-risk patients for metastatic cancer progression.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 5, 2007

New blood thinner may work without bleeding risk

A new thrombin-receptor antagonist (TRA) has shown significant reduction in serious cardiovascular events, mainly heart attacks, with no increase in bleeding risks in a high-risk patient population. The study found a 46% lowering in serious cardiovascular events, an early and strong efficacy signal for this novel antiplatelet compound.